Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 4 studies | 32% ± 13% | |
myofibroblast cell | 3 studies | 41% ± 16% | |
smooth muscle cell | 3 studies | 55% ± 7% | |
connective tissue cell | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 14935.34 | 965 / 966 | 55% | 2.83 | 292 / 527 |
thymus | 99% | 492.74 | 646 / 653 | 42% | 2.27 | 253 / 605 |
adrenal gland | 24% | 71.55 | 63 / 258 | 67% | 35.73 | 153 / 230 |
blood vessel | 76% | 361.03 | 1010 / 1335 | 0% | 0 | 0 / 0 |
liver | 43% | 49.35 | 97 / 226 | 23% | 2.40 | 94 / 406 |
stomach | 28% | 55.04 | 102 / 359 | 35% | 1.91 | 101 / 286 |
pancreas | 2% | 1.66 | 8 / 328 | 40% | 3.16 | 71 / 178 |
bladder | 10% | 7.95 | 2 / 21 | 22% | 1.51 | 110 / 504 |
esophagus | 29% | 34.07 | 421 / 1445 | 1% | 0.11 | 2 / 183 |
heart | 19% | 39.38 | 162 / 861 | 0% | 0 | 0 / 0 |
brain | 12% | 44.63 | 325 / 2642 | 5% | 0.21 | 38 / 705 |
eye | 0% | 0 | 0 / 0 | 13% | 0.32 | 10 / 80 |
prostate | 9% | 8.05 | 23 / 245 | 2% | 0.09 | 9 / 502 |
ovary | 1% | 0.77 | 1 / 180 | 10% | 0.31 | 44 / 430 |
adipose | 10% | 45.71 | 126 / 1204 | 0% | 0 | 0 / 0 |
skin | 7% | 7.60 | 133 / 1809 | 1% | 0.03 | 7 / 472 |
muscle | 9% | 15.04 | 70 / 803 | 0% | 0 | 0 / 0 |
lung | 2% | 1.12 | 9 / 578 | 4% | 0.34 | 42 / 1155 |
breast | 1% | 6.66 | 5 / 459 | 2% | 0.16 | 19 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
uterus | 1% | 0.34 | 1 / 170 | 1% | 0.06 | 4 / 459 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 5 / 901 |
spleen | 0% | 0.27 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.09 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010172 | Biological process | embryonic body morphogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0043010 | Biological process | camera-type eye development |
GO_0008283 | Biological process | cell population proliferation |
GO_0007399 | Biological process | nervous system development |
GO_0001654 | Biological process | eye development |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | MAB21L2 |
Protein name | Protein mab-21-like 2 |
Synonyms | |
Description | FUNCTION: Required for several aspects of embryonic development including normal development of the eye. . |
Accessions | Q9Y586 ENST00000317605.6 |